Total joint replacement is a highly successful treatment option for people affected by severe osteoarthritis (OA), however, the mismatch between resources and demand for this surgery means that many patients face long wait times while enduring worsening pain and disability. The Alberta Hip and Knee Program is a centralized intake system for patients referred for total joint replacement assessment. Over 3000 patients are assessed annually at the Calgary location (Alberta Hip and Knee Clinic at Gulf Canada Square) where previously patients waited an average of 43 weeks for a surgical consult then an additional 30 weeks until surgery. Given that many elective surgeries in Alberta have been cancelled in response to the COVID19 pandemic, these wait times have increased significantly, with no clearing of the surgical backlog for the foreseeable future. Long wait times for patients can become a spiral of more debility, less mobility, and subsequent weight gain. The current standard of care for patients with obesity awaiting surgery provides little support or guidance beyond general advice about the importance of a healthy weight and remaining active. This waiting period represents an untapped window of opportunity to intervene and help patients with obesity and OA to lessen their disease burden and improve overall health, while addressing patient priorities such as regaining lost function and improving quality of life. Many patients with osteoarthritis also have obesity. The best practices in obesity treatment requires a multidisciplinary approach. Our aim is to conduct a pilot randomized controlled trial (RCT) to evaluate the feasibility of incorporating the multidisciplinary Alberta Obesity Centre program into the clinical care pathway for patients with obesity and OA while they await surgical evaluation at the Alberta Hip and Knee Clinic at Gulf Canada Square. The results of this feasibility trial will help inform a larger scale trial that will be powered for clinical and health economics outcomes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
70
Weight management services
Multi-disciplinary obesity management
Living Your Best Life with Osteoarthritis Handbook
GLA:D physiotherapy programs.
University of Calgary
Calgary, Alberta, Canada
Determine the number of adults with osteoarthritis and obesity that are eligible to participate in the trial
The number of patients approached
Time frame: 0-12 months
The number of these adults with osteoarthritis and obesity who would be willing to take part in this trial
The number of patients who actually enroll
Time frame: 0-12 months
The characteristics of these adults with osteoarthritis and obesity who are willing to take part in the trial
Patient sex, gender, age, and medical history
Time frame: 0-12 months
The number and percentage of participants retained at 12-months
Number and percentage of patients attending at 12-month follow up and reasons for drop-out
Time frame: 0-12 months
Change in body mass
Change in body mass (weight loss)
Time frame: 0-12 months
Decision to proceed with joint replacement surgery
Yes/no decision to proceed with joint replacement surgery
Time frame: 12 months
Change in waist circumference
waist circumference (centimetres)
Time frame: 0-12 months
Change in blood pressure
blood pressure (millimetres of mercury)
Time frame: 0-12 months
Change in blood lipid profile
blood lipids
Time frame: 0-12 months
Change in glycemic control
glycated hemoglobin (HbA1c)
Time frame: 0-12 months
Change in quality of life
Quality of life measured by the Alberta Bone and Joint Health Institute Hip and Knee Replacement Outcomes Tool
Time frame: 0-12 months
Change in medication usage
All prescription medications will be tracked and recorded by a study physician
Time frame: 0-12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.